NDC 71335-3103 – Acyclovir

Acyclovir 400 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC71335-3103

Product details

Brand name
Acyclovir
Generic name
Acyclovir
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA210401
Marketed since
June 20, 2023
Listing expires
December 31, 2027
Pharmacologic class
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Acyclovir →

Package NDC codes (10)

Package NDCDescriptionSince
71335-3103-0120 TABLET in 1 BOTTLE (71335-3103-0)Mar 16, 2026
71335-3103-120 TABLET in 1 BOTTLE (71335-3103-1)Mar 16, 2026
71335-3103-228 TABLET in 1 BOTTLE (71335-3103-2)Mar 16, 2026
71335-3103-330 TABLET in 1 BOTTLE (71335-3103-3)Mar 16, 2026
71335-3103-450 TABLET in 1 BOTTLE (71335-3103-4)Mar 16, 2026
71335-3103-515 TABLET in 1 BOTTLE (71335-3103-5)Mar 16, 2026
71335-3103-660 TABLET in 1 BOTTLE (71335-3103-6)Mar 16, 2026
71335-3103-725 TABLET in 1 BOTTLE (71335-3103-7)Mar 16, 2026
71335-3103-810 TABLET in 1 BOTTLE (71335-3103-8)Mar 16, 2026
71335-3103-940 TABLET in 1 BOTTLE (71335-3103-9)Mar 16, 2026

Other Acyclovir products